| Fibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunction T Shimizu, N Narang, P Chen, B Yu, M Knapp, J Janardanan, J Blair, ... JCI insight 2 (13), 2017 | 72 | 2017 |
| ROCK as a therapeutic target for ischemic stroke N Sladojevic, B Yu, JK Liao Expert review of neurotherapeutics 17 (12), 1167-1177, 2017 | 52 | 2017 |
| Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening B Yu, N Sladojevic, JE Blair, JK Liao Expert opinion on therapeutic targets 24 (1), 47-62, 2020 | 34 | 2020 |
| Improvements in patient safety culture: a national Taiwanese survey, 2009–16 B Yu, CF Wen, HL Lo, HH Liao, PC Wang International Journal for Quality in Health Care 32 (1), A9-A17, 2020 | 21 | 2020 |
| Impact of patient-reported outcome measurement in heart failure clinic on clinician health Status assessment and patient experience: a substudy of the PRO-HF trial AT Sandhu, J Zheng, NM Kalwani, A Gupta, J Calma, M Skye, R Lan, ... Circulation: Heart Failure 16 (2), e010280, 2023 | 19 | 2023 |
| Regulator of G‐Protein Signaling 5 Maintains Brain Endothelial Cell Function in Focal Cerebral Ischemia N Sladojevic, B Yu, JK Liao Journal of the American Heart Association 9 (18), e017533, 2020 | 14 | 2020 |
| Relationship between global longitudinal strain and left ventricular diastolic function B Yu, I Lin, B Cornish, K Lin, L Park, G Perla, S Lin Journal of the American College of Cardiology 73 (9S1), 1675-1675, 2019 | 11 | 2019 |
| Involvement of Rho-associated coiled-coil containing kinase (ROCK) in BCR-ABL1 tyrosine kinase inhibitor cardiovascular toxicity B Yu, AEG Osman, N Sladojevic, N Prabhu, HC Tai, D Chen, G Perla, ... Cardio Oncology 4 (3), 371-383, 2022 | 4 | 2022 |
| Deconvoluting the cells of the human heart with iPSC technology: Cell types, protocols, and uses B Yu, SR Zhao, CD Yan, M Zhang, JC Wu Current Cardiology Reports 24 (5), 487-496, 2022 | 4 | 2022 |
| ABL Tyrosine Kinase Inhibitors (TKIs) Are Associated with Increased Rho-Associated Kinase (ROCK) Activity That May Contribute to Vascular Toxicity in Patients with Chronic … A Osman, B Yu, N Glavin, TS Polonsky, JK Liao, RA Larson Blood 132, 1739, 2018 | 3 | 2018 |
| The feasibility of global longitudinal strain in clinical practice and relationship with ejection fraction I Lin, B Yu, H Boyd, S Winchester, E Caldwell, K Lin, B Cornish, S Lin Journal of the American College of Cardiology 71 (11S), A1716-A1716, 2018 | 1 | 2018 |
| Clinical Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic AT Sandhu, J Calma, M Skye, NM Kalwani, J Zheng, J Schirmer, N Din, ... Circulation, 2024 | | 2024 |
| Molecular Mechanisms for Statin Pleiotropy and Possible Clinical Relevance in Cardiovascular Disease B Yu, N Sladojevic, JK Liao Pharmaceutical Biocatalysis, 311-345, 2020 | | 2020 |
| Rho-Associated Kinase Activity Correlates With the Presence of Diastolic Dysfunction in Patients With Normal Left Ventricular Ejection Fraction B Yu, H Al Kassem, L Ma, T Allan, K Dryer, L Park, J Malwankar, G Perla, ... Circulation 140 (Suppl_1), A14476-A14476, 2019 | | 2019 |
